- Home
- LEXX vs TCBS Comparison
LEXX vs TCBS Comparison
Compare LEXX & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- TCBS
- Stock Information
- Founded
- LEXX 2004
- TCBS 1934
- Country
- LEXX Canada
- TCBS United States
- Employees
- LEXX N/A
- TCBS N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- LEXX Health Care
- TCBS Finance
- Exchange
- LEXX Nasdaq
- TCBS Nasdaq
- Market Cap
- LEXX 49.3M
- TCBS 46.6M
- IPO Year
- LEXX N/A
- TCBS N/A
- Fundamental
- Price
- LEXX $3.08
- TCBS $14.88
- Analyst Decision
- LEXX Strong Buy
- TCBS
- Analyst Count
- LEXX 2
- TCBS 0
- Target Price
- LEXX $11.00
- TCBS N/A
- AVG Volume (30 Days)
- LEXX 100.1K
- TCBS 1.8K
- Earning Date
- LEXX 11-18-2024
- TCBS 11-20-2024
- Dividend Yield
- LEXX N/A
- TCBS 1.07%
- EPS Growth
- LEXX N/A
- TCBS N/A
- EPS
- LEXX N/A
- TCBS N/A
- Revenue
- LEXX $411,019.00
- TCBS $9,785,000.00
- Revenue This Year
- LEXX $82.02
- TCBS N/A
- Revenue Next Year
- LEXX $95.09
- TCBS N/A
- P/E Ratio
- LEXX N/A
- TCBS N/A
- Revenue Growth
- LEXX 34.05
- TCBS N/A
- 52 Week Low
- LEXX $0.85
- TCBS $11.78
- 52 Week High
- LEXX $6.85
- TCBS $15.24
- Technical
- Relative Strength Index (RSI)
- LEXX 50.45
- TCBS 64.55
- Support Level
- LEXX $3.06
- TCBS $14.75
- Resistance Level
- LEXX $3.39
- TCBS $14.80
- Average True Range (ATR)
- LEXX 0.21
- TCBS 0.11
- MACD
- LEXX 0.00
- TCBS -0.01
- Stochastic Oscillator
- LEXX 65.71
- TCBS 80.82
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.